The role of NF-κB in diabetic cardiomyopathy
Diabetic cardiomyopathy (DCM), a major risk factor contributing to diabetes-related morbidity and mortality, manifests as a pathophysiologic condition in humans independently of coronary artery disease or hypertension. Several transcription factors intricately participate in the initiation and progr...
Saved in:
Main Authors: | Huang-Jun Liu, Le-Kun Gui, Han Wei, Xing-Yu Zhou, Zhen-Lan Liu, Li-Jun Jin |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2024-12-01
|
Series: | All Life |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/26895293.2024.2397402 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Diabetic cardiomyopathy: pathophysiology, imaging assessment and therapeutical strategies
by: Vincenzo Rizza, et al.
Published: (2024-12-01) -
Investigating the NF-κB signaling pathway in heart failure: Exploring potential therapeutic approaches
by: Mohsen Ghiasi
Published: (2024-12-01) -
Regulation of pyroptosis by NF-κB signaling
by: Ling Yang, et al.
Published: (2025-01-01) -
The role of multimodality imaging in diabetic cardiomyopathy: a brief review
by: Fadi W. Adel, et al.
Published: (2024-12-01) -
PPARβ/δ prevents inflammation and fibrosis during diabetic cardiomyopathy
by: Adel Rostami, et al.
Published: (2024-12-01)